Compare FRPT & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRPT | PGNY |
|---|---|---|
| Founded | 2004 | 2008 |
| Country | United States | United States |
| Employees | N/A | 856 |
| Industry | Packaged Foods | Misc Health and Biotechnology Services |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | 2014 | 2019 |
| Metric | FRPT | PGNY |
|---|---|---|
| Price | $56.38 | $30.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 10 |
| Target Price | ★ $76.94 | $26.50 |
| AVG Volume (30 Days) | ★ 1.6M | 1.4M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 183.87 | 14.04 |
| EPS | ★ 0.91 | 0.29 |
| Revenue | $1,102,015,000.00 | ★ $1,288,661,000.00 |
| Revenue This Year | $11.34 | $8.87 |
| Revenue Next Year | $9.13 | $9.76 |
| P/E Ratio | ★ $61.96 | $104.21 |
| Revenue Growth | ★ 13.01 | 10.40 |
| 52 Week Low | $46.45 | $16.10 |
| 52 Week High | $86.00 | $30.33 |
| Indicator | FRPT | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 53.79 | 81.61 |
| Support Level | $48.06 | $23.93 |
| Resistance Level | $56.51 | N/A |
| Average True Range (ATR) | 3.32 | 0.83 |
| MACD | 0.61 | 0.19 |
| Stochastic Oscillator | 57.20 | 97.96 |
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (likely representing well north of 90% of sales), with cats and treats nascent contributors. Geographically, the company's home US market, where all its food is produced, accounts for nearly all of sales, with exports to Canada, the United Kingdom, and other European countries being very small contributors.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.